Filing Flows › Pfizer (PFE) › Operating margin
Pfizer (PFE) operating margin by quarter
Pfizer's operating margin was 20.4% in Q3 2026 (third quarter 2026), -1.4 pts from Q1 2026. Over the last 5 quarters it ranged from 20.0% (Q3 2025) to 21.8% (Q1 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 20.4% | -1.4 pts | +0.4 pts |
| Q1 2026 | 21.8% | +1.8 pts | +1.5 pts |
| Q3 2025 | 20.0% | -0.9 pts | — |
| Q2 2025 | 20.9% | +0.6 pts | — |
| Q1 2025 | 20.3% | — | — |
Q3 2026 at a glance
Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.
Questions
What is Pfizer's operating margin?
Pfizer's operating margin was 20.4% in Q3 2026 (third quarter 2026), -1.4 pts from Q1 2026.
How has Pfizer's operating margin changed?
Over the last 5 quarters it ranged from 20.0% (Q3 2025) to 21.8% (Q1 2026).